Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.
Brandow
Amanda M
AM
Jirovec
Danielle L
DL
Panepinto
Julie A
JA
D000755:Anemia, Sickle Cell / Q000150:complications / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D002648:Child; D003267:Contraception / Q000706:statistics & numerical data; D003625:Data Collection; D016903:Drug Monitoring / Q000706:statistics & numerical data; D004363:Drug Utilization; D005260:Female; D019983:Guideline Adherence; D006405:Hematology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008495:Medical Oncology; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010349:Patient Compliance / Q000706:statistics & numerical data; D010372:Pediatrics; D010820:Physicians / Q000523:psychology / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians'
D006918:Hydroxyurea